GlassScriptPhysician profile
Susan M Mucha
NPI 1447415906
$2,825.66
in general payments reported to CMS, 2019-2025
23 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $250 · 2021: $107 · 2022: $142 · 2023: $515 · 2024: $231 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $569.93 | 2019-2024 | |
| Inspire Medical Systems, INC. | $495.69 | 2019-2025 | Inspire |
| Glaxosmithkline, LLC. | $248.62 | 2019-2025 | Trelegy Ellipta |
| Harmony Biosciences LLC | $240.76 | 2020-2024 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.23 | 2019-2022 | |
| Zoll Respicardia, INC. | $176.94 | 2019 | |
| Pulmonx Corporation | $115.99 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $115.08 | 2023-2025 | Lumryz |
| Azurity Pharmaceuticals, INC. | $84.13 | 2024-2025 | Horizant |
| Octapharma USA, INC. | $79.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $78.98 | 2019-2025 | Tezspire |
| Lilly USA, LLC | $78.63 | 2025 | Zepbound |
| Axsome Therapeutics, INC. | $59.36 | 2023-2025 | Sunosi |
| Resmed Corp | $58.32 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $50.30 | 2023-2025 | Quviviq, Quviviq |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $45.21 | 2023 | Belsomra |
| Pfizer INC. | $43.36 | 2019 | |
| Baxter Healthcare | $22.69 | 2023 | Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $20.56 | 2024 | (Ak6) Vest Therapy |
| Mallinckrodt Enterprises LLC | $19.30 | 2019 | |
| Abbott Laboratories | $14.92 | 2019 | |
| Grifols USA, LLC | $12.92 | 2019 | |
| Eisai INC. | $12.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Mucha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.